G25.79 Other drug induced movement disorders

Name of the Condition

• Other Drug Induced Movement Disorders
• ICD-10 Code: G25.79

Summary

Other drug induced movement disorders are a category of conditions resulting from medication use that disrupt normal movement patterns. These disorders involve involuntary movements or altered motor control due to pharmaceutical agents, with the term "other" indicating specific but less common types not classified elsewhere.

Causes

These disorders are caused by medications that affect neurotransmitter systems, particularly dopamine, in the brain. Drugs such as antipsychotics, antiemetics, antidepressants, and certain anticonvulsants can interfere with motor pathways, leading to movement abnormalities. The specific mechanism depends on the drug's pharmacological action.

Risk Factors

• Use of medications known to affect motor function
• High doses or prolonged treatment with such drugs
• Pre-existing neurological vulnerabilities
• Advanced age, which may increase susceptibility to side effects

Symptoms

• Involuntary muscle movements (e.g., dystonia, akathisia, or chorea)
• Tremors or rhythmic shaking
• Muscle rigidity or stiffness
• Restlessness or inability to stay still
• Abnormal postures or repetitive motions

Diagnosis

Diagnosis involves a clinical evaluation of symptoms and medication history, with a focus on identifying temporal relationships between drug use and movement abnormalities. Neurological examination and differential diagnosis help rule out other conditions.

Treatment Options

• Discontinuation or adjustment of the offending medication
• Use of medications like anticholinergics or benzodiazepines to manage symptoms
• Physical therapy to improve movement and coordination

Prognosis and Follow-Up

Prognosis depends on the specific disorder and timely intervention. Symptoms often improve with medication adjustment, but some may persist. Regular follow-up is necessary to monitor for recurrence or new symptoms.

Complications

• Persistent movement abnormalities
• Functional impairment affecting daily activities
• Psychological distress due to symptoms
• Potential for medication non-adherence

Lifestyle & Prevention

• Regular review of medication regimens with healthcare providers
• Monitoring for early signs of movement changes
• Avoiding unnecessary use of high-risk medications
• Maintaining open communication about side effects

When to Seek Professional Help

Seek medical attention if new or worsening involuntary movements occur, especially after starting or changing medications. Prompt evaluation can prevent progression and guide appropriate management.

Tips for Medical Coders

Document the specific drug or class of drugs associated with the movement disorder, as well as the temporal relationship between medication use and symptom onset. Ensure the diagnosis aligns with clinical findings and medication history to support accurate coding.